CE Schedule

CE Schedule

9:30 am
REGISTRATION DESK OPENS
Paris Las Vegas, Conference Center
12:30 pm
APPLYING RYAN'S LAW: THE COMPASSIONATE USE OF CANNABIS IN HEALTHCARE FACILITIES
Jill Simonian, PharmD, Codi Peterson, PharmD, Kari Franson, PharmD, & Paul Lofholm, PharmD

Click for Description & Learning Objectives

Description: This presentation will provide pharmacists with an understanding of Ryan’s Law, including a description of the potential conflicts between federal and state Cannabis laws and policy implementation methods for compliance with this law while minimizing risk to the institution. Participants will also learn basic information about the cannabis plant, the types of formulations available, and common adverse effects and drug interactions.

Learning Objectives:
1. Differentiate the types of medical cannabis used for compassionate purposes.
2. Explain the most common cannabis adverse effects and drug interactions.
3. Discuss the status of cannabis according to California laws and regulations.
4. Compare and contrast federal and state cannabis laws.
5. Identify the key features and requirements of Ryan’s Law.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-004-L01-P; 0113-0000-23-004-L01-T
12:30 pm
TO BE OR NOT TB: ROLE OF PHARMACISTS IN DETECTING AND MANAGING LTBI
Yelim Joung, PharmD, Jenny Soobin Kim, PharmD & Kyle Christopher Fischer, PharmD , Allison Chacon, PharmD, APh

Click for Description & Learning Objectives

Description: The program will address the current LTBI guidelines, best practices for intradermal injection technique, and role of the pharmacist in initiating and managing the disease. It will provide pertinent information on how to implement clinical service and continuity of care. The CDC estimates that nearly 13 million Americans have latent tuberculosis (LTBI) and that untreated or improperly treated LTBI is responsible for 80% of the cases of tuberculosis (TB). Pharmacists can play an important role in initiating, managing, and monitoring medications used to treat LTBI through directly-observed or self-administered therapy to ensure optimal treatment outcomes, minimize adverse events, and ensure completion of treatment.

Learning Objectives:
1. Compare and contrast between LTBI and active TB disease and treatment.
2. Discuss appropriate technique for PPD placement and interpretation to identify LTBI.
3. Apply treatment guidelines for LTBI to optimize treatment outcomes.
4. Explain how pharmacists can play a role in continuity of care in LTBI treatment.

Location: CONCORDE B

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-024-L01-P; 0113-0000-23-024-L01-T
12:30 pm
INTEGRATING A RESIDENCY PROGRAM INTO A COMMUNITY PHARMACY
Richard Dang, PharmD, APh, BCACP, FCPhA & Micah Hata, PharmD

Click for Description & Learning Objectives

Description: Community-based pharmacy residency programs (CPRP) are postgraduate training programs that take place in community pharmacies (including chain, supermarket-based, outpatient health-system, and independent pharmacies) and ambulatory clinics with a focus on diverse experiences in patient care, leadership/management, practice management, and education. There is an opportunity to expand these unique training opportunities to develop future community-based practitioners and leaders.

Learning Objectives:
1. Describe the standards and objectives of a community-based pharmacy residency program.
2. Identify opportunities and challenges of creating and integrating a residency program into a community pharmacy practice.
3. Evaluate existing programs and review best practices of operating a residency program.

Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-016-L04-P; 0113-0000-23-016-L04-T
1:45 pm
NEW COMPOUNDING OPPORTUNITIES AND HOW TO MARKET YOUR PRACTICE
Ranel Larsen, PharmD & Erin Michael, MBA, MS, CPhT

Click for Description & Learning Objectives

Description: Emerging trends and new treatment modalities in the field of compounding pharmacy are helping patients and giving prescribers novel therapies. During this session explore some of the hot topics in compounding such as treatment for autoimmune, dermatological, and mental health conditions. Then, explore marketing opportunities on how to inform both prescribers and patients on these compounding niches to grow your pharmacy business.

Learning Objectives:
1. Describe the role compounding pharmacy plays in helping patients to improve their quality of life.
2. Explain novel treatment modalities for patients with autoimmune disease, dermatological conditions, and more.
3. Discuss the importance of marketing a compounding pharmacy to prescribers and patients.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-015-L07-P; 0113-0000-23-015-L07-T
1:45 pm
UPDATE: NEW CDC GUIDELINES FOR PRESCRIBING OPIOIDS FOR PAIN
Melissa Durham, PharmD & Allison Chacon, PharmD

Click for Description & Learning Objectives

Description: This session will be an interactive, case-based review of the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain.

Learning Objectives:
1. Outline key updates to the CDC Guideline for Prescribing Opioids for Chronic Pain, 2016.
2. Incorporate the updated CDC Guideline for Prescribing Opioids to practice for safe and competent prescribing and improved HRQoL for patients with chronic pain.
3. Apply knowledge of acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain.

Location: CONCORDE B

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-011-L08-P; 0113-0000-23-011-L08-T
1:45 pm
HIGH PERFORMANCE: HOW PHARMACISTS CAN PREVENT BURNOUT & BE ROCKSTARS TO PATIENTS, TEAM & FAMILY
Michelle Sherman, PharmD

Click for Description & Learning Objectives

Description: The COVID-19 pandemic transformed pharmacy & pharmacist care- burnout is rampant, reimbursement plummeting. Preventing burnout and creating a high performance life as a pharmacist transforms the pharmacist, their team, patients and family.

Learning Objectives:
1. Demonstrate the capabilities and value proposition of specialty pharmacy with a focus on health system specialty pharmacy.
2. Discuss how outcomes data meet payer and/or manufacturer reporting requirements.
3. Explain why collecting, tracking, and reporting clinical outcomes benefit specialty pharmacy practice.
4. Discuss best practices for data evaluation and reporting outcomes.
5. Identify strategies to communicate the value of outcomes research to stakeholders.

Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-022-L01-P; 0113-0000-23-022-L01-T
3:00 pm
SGLT TOO? UPDATES IN HEART FAILURE WITH REDUCED EJECTION FRACTION
Kanika Bhandari, PharmD

Click for Description & Learning Objectives

Description: This presentation will provide pharmacists with updates to the 2022 AHA/ACC/HFSA heart failure guidelines, specifically examining SGLT2 inhibitors and the literature behind their benefits.

Learning Objectives:
1. Outline current guideline directed medical therapy for heart failure with reduced ejection fraction (HFrEF).br> 2. Evaluate the literature regarding SGLT2 inhibitors and their role in patients with HFrEF.br> 3. Identify optimal patients to initiate on SGLT2 inhibitors.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-005-L01-P; 0113-0000-23-005-L01-T
3:00 pm
IT’S QUITTING TIME: PHARMACISTS’ PRESCRIBING MEDICATIONS FOR TOBACCO CESSATION
Robin Corelli, PharmD, CTTS & Lisa Kroon, PharmD

Click for Description & Learning Objectives

Description: This session will bring pharmacists up to speed with prescribing medications for tobacco cessation.

Learning Objectives:
1. Compare the available FDA-approved medication options, including the safety and efficacy data, for tobacco cessation.
2. Develop a treatment regimen that incorporates effective tobacco cessation medications, including drugs, doses, routes, and frequency of administration.
3. Describe services provided by the Kick It California (1-800-300-8086) and national tobacco quitlines (1-800 QUIT-NOW).

Location: CONCORDE B

Click Here for Session Handouts

2.0 CE Hours 0113-0000-23-017-L01-P; 0113-0000-23-017-L01-T
3:00 pm
COMORBID WANDERLUST: CHRONIC DISEASE CONSIDERATIONS IN TRAVEL HEALTH
Keri Hurley-Kim, PharmD, MPH, BCACP, APh

Click for Description & Learning Objectives

Description: Safe international travel can be possible for many people with chronic diseases with sufficient education and preparation. Pharmacists in a variety of settings are well-positioned to help people with stable chronic conditions travel safely regardless of whether comprehensive travel health services are part of your practice. This session will review general and specific considerations for management of diabetes, chronic respiratory conditions, heart failure, and other conditions during international travel.

Learning Objectives:
1. Describe the intersection of travel health and chronic disease management.
2. Identify patients with travel health needs, chronic disease needs or both during a travel health appointment or other encounter.
3. Introduce useful technology and other tools to facilitate safe travel in patients with chronic diseases.
4. Outline considerations that increase the risk of chronic disease exacerbation or complications during travel.

Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-007-L01-P; 0113-0000-23-007-L01-T
4:30 - 7:30 pm
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATERS
RIVOLI A
5:30 - 6:30 pm
OPENING RECEPTION
RIVOLI A
6:30 pm
REGISTRATION DESK CLOSES
Paris Las Vegas, Conference Center
9:30 am
REGISTRATION DESK OPENS
Paris Las Vegas, Conference Center
1:45 pm
VALUE IS IN THE EYE OF THE BEHOLDER - WHAT IS VALUABLE TO SPECIALTY PHARMACY STAKEHOLDERS
David Mitchell, PharmD, MBA, CSP, FCPhA & Ethan T. Huynh, PharmD, APh, BCGP, CPBS, IgCP

Click for Description & Learning Objectives

Description: This session will provide specialty pharmacy capabilities and the data which demonstrates these capabilities. We will then discuss the value of these capabilities and data from the perspective of payers and manufacturers.

Learning Objectives:
1. Demonstrate the capabilities and value proposition of specialty pharmacy with a focus on health system specialty pharmacy.
2. Discuss how outcomes data meet payer and/or manufacturer reporting requirements.
3. Explain why collecting, tracking, and reporting clinical outcomes benefit specialty pharmacy practice.
4. Discuss best practices for data evaluation and reporting outcomes.
5. Identify strategies to communicate the value of outcomes research to stakeholders.

Location: VENDOME C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-023-L04-P; 0113-0000-23-023-L04-T
3:00 pm
STERILE COMPOUNDING: PLANNING FOR THE FUTURE LANDSCAPE
Linda Panofsky, PharmD

Click for Description & Learning Objectives

Description: The regulations impacting compounding are complex and seem to change rapidly. In this session learn essential components of a compliant compounding layout that will stand the test of time, plus how to leverage modern resources to ensure compliance.

Learning Objectives:
1. Outline the key elements of a compliant cleanroom that have expected longevity.
2. Describe the overall intent of compounding compliance and the regulations that drive it.
3. List the 4 main best practice elements of sterile compounding that are likely to become required.
4. Apply practice specific based analysis to designing a cleanroom.

Location: VENDOME C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-008-L07-P; 0113-0000-23-008-L07-T
4:30 - 7:30 am
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATERS
RIVOLI A
5:30 - 6:30 am
OPENING RECEPTION
RIVOLI A
6:30 pm
REGISTRATION DESK CLOSES
Paris Las Vegas, Conference Center
9:30 am
REGISTRATION DESK OPENS
Paris Las Vegas, Conference Center
4:30 - 7:30 pm
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATERS
RIVOLI A
5:30 - 6:30 pm
OPENING RECEPTION
RIVOLI A
6:30 pm
REGISTRATION DESK CLOSES
Paris Las Vegas, Conference Center
7:00 am
REGISTRATION DESK OPENS
Paris Las Vegas, Conference Center
8:00 am
CAN YOU HELP ME? THE PHARMACISTS ROLE IN PROVIDING CONTRACEPTION SERVICES
Kathleen Besinque, PharmD, M.S. Ed, FCSHP, FASHP, FCPhA & Sarah McBane, PharmD, BCPS, FCCP, FCPhA, FCSHP, APh

Click for Description & Learning Objectives

Description: Rates of unintended pregnancy in the US continue to be high, in part due to reduced access and incorrect use of highly effective contraception methods. Discussion of contraceptive options using patient-centered, shared decision-making techniques can improve utilization. Understanding updated evidenced based guidelines is necessary for pharmacists to provide optimal contraception care. This interactive lecture will address these issues in order to decrease the gaps in access to contraception, and help prevent unintended pregnancy.

Learning Objectives:
1. Discuss rates of unintended pregnancy and contraceptive use in the US.
2. Compare the contraception options available in the US.
3. Apply evidenced-based guidelines to contraceptive provision using the CDC MEC.
4. Provide resources and referral to persons seeking care for reproductive health related conditions.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-006-L01-P; 0113-0000-23-006-L01-T
8:00 am
CALIFORNIA PHARMACY LAW UPDATE: 2023, Q1 (NON-RECORDED)
Tony J. Park, PharmD, JD & Anne Sodergren

Click for Description & Learning Objectives

Description: Join Board of Pharmacy Executive Director Anne Sodergren and CPhA General Counsel Tony J. Park, Pharm.D., J.D. as they highlight changes in state and federal pharmacy laws for 2023. This session is an opportunity to identify and discuss overarching trends in the regulatory climate for California pharmacists.

Learning Objectives:
1. Describe changes in state and federal pharmacy laws for 2023.
2. Explain overarching trends in the regulatory climate for California pharmacists.
3. Summarize current pharmacy standards of practice.
4. Identify resources for staying current on regulatory issues.

Location: CONCORDE B

No Handouts for this Session

1.0 CE Hour 0113-0000-23-021-L03-P; 0113-0000-23-021-L03-T
8:00 am
MAKING THE CASE FOR ADVANCED PHARMACY TECHNICIAN ROLES
Ryan Burke, PharmD

Click for Description & Learning Objectives

Description: This session will provide an overview of advanced pharmacy technician roles and describe how these roles impact pharmacy practice.

Learning Objectives:
1. Describe advanced pharmacy technician roles.
2. Explain the impact advanced pharmacy technician roles have on the practice of pharmacy.
3. Identify practice settings for advanced pharmacy technician roles.

Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-018-L04-P; 0113-0000-23-018-L04-T
9:10-10:30 am
DR. MICHAEL HOGUE KEYNOTE & ANNUAL BUSINESS MEETING
VENDOME A
10:45 am
ANNUAL IMMUNIZATION UPDATE: 2023
Richard Dang, PharmD, APh, BCACP, FCPhA & Michael Hogue, PharmD, FAPhA, FNAP, FFIP

Click for Description & Learning Objectives

Description: An up-to-date knowledge of CDC immunization recommendations is essential for pharmacists initiating and administering vaccines in California. This program will focus on key changes to the CDC’s annual immunization schedules and new vaccine products approved in the last year. Patient cases will highlight updates to influenza, pneumococcal, COVID-19 and other routine or recommended vaccines for use in adult and pediatric populations.

Learning Objectives:
1. Review and interpret important changes to ACIP recommendations and the CDC’s immunization schedules for adults and children in the United States.
2. Review newly licensed vaccine products and examine data on efficacy and safety.
3. Identify strategies to reduce vaccine hesitancy and increase immunization rates.
4. Assess patient profiles and develop recommendations for immunizations based on age, medical indications, or other risk factors.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-019-L06-P; 0113-0000-23-019-L06-T
10:45 am
AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) UPDATE: USE OF VACCINES IN IMMUNOSUPPRESSED CONDITIONS
Nora Garabedian, PharmD, Natalie Kanimian, PharmD, & Negin Sazgar, PharmD

Click for Description & Learning Objectives

Description: An overview of the expanded indications for some vaccines in patients with rheumatic and musculoskeletal diseases (RMDs), as well as guidance on whether to hold immunosuppressive medications or delay vaccination to maximize vaccine immunogenicity. Safe approaches to the use of live-attenuated vaccines in patients on immunosuppressive medications will also be addressed.

Learning Objectives:
1. Identify and apply appropriate resources for immunization recommendations.
2. Review and interpret the American College of Rheumatology (ACR) vaccination recommendation in patients with rheumatic and musculoskeletal diseases (RMDs).
3. Describe the use of live-attenuated vaccines in patients on immunosuppressive medications in patients with RMDs.
4. Assess the relative timing of vaccinations and immunosuppressive medications to maximize immunogenicity.

Location: CONCORDE B

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-014-L01-P; 0113-0000-23-014-L01-T
10:45 am
INTESTINAL MICROBIOTA AND METABOLIC SYNDROME - THE INFLUENCE OF FOOD AND SUPPLEMENTS
Cynthia Lieu, PharmD

Click for Description & Learning Objectives

Description: What is the relationship between the intestinal microbiota and metabolic syndrome? How can changes in nutritional intake and the use of supplements influence the intestinal microbiota in individuals with metabolic syndrome?

Learning Objectives:
1. Discuss the relationship between the intestinal microbiota and metabolic syndrome.
2. Describe how changes in nutritional intake can influence the intestinal microbiota in individuals with metabolic syndrome.
3. Describe how the use of supplements can influence the intestinal microbiota in individuals with metabolic syndrome.


Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-020-L01-P; 0113-0000-23-020-L01-T
12 - 1:30 pm
RODDY CHONG KEYNOTE & AWARDS CEREMONY
VENDOME A
1:30 - 3:30 pm
EXHIBIT HALL, POSTER SESSIONS, PRODUCT THEATER & LUNCH
RIVOLI A
6:00 pm
REGISTRATION DESK CLOSES
Paris Las Vegas, Conference Center
8:30 - 11 pm
OH, LA, LA! A NIGHT IN PARIS
VENDOME A
7:00 am
REGISTRATION DESK OPENS
Paris Las Vegas, Conference Center
8:00 am
SPECIALTY AND RETAIL PHARMACY: YOU CAN'T IMPROVE WHAT YOU CAN'T MEASURE: FROM ACCREDITATION TO VALIDATION
Mei Tang, PharmD, MBA & John McMillen

Click for Description & Learning Objectives

Description: Achieving the ACHC and URAC pharmacy accreditation. Maintaining compliance after accreditation.

Learning Objectives:
1. To gain insight on pharmacy accreditation.
2. To learn the key success factors to achieve accreditation.
3. To learn The Compliance Team’s Clinical.Disease Management Certification Program.
4. To understand the importance of maintaining compliance after accreditation.
5. To learn to prepare URAC measure reporting and validation.

Location: VERSAILLES 1

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-025-L04-P; 0113-0000-23-025-L04-T
9:10-10:30 am
DR. MICHAEL HOGUE KEYNOTE & ANNUAL BUSINESS MEETING
VENDOME A
10:45 am
TRENDS IN THIRD-PARTY PAYOR AUDITS AND EFFECTIVE RESPONSE STRATEGIES
Mark Boesen, PharmD, JD & Mark Ziegler, PharmD, MBA

Click for Description & Learning Objectives

Description: An introduction to Andragogical and Pedagogical principles and how they can be used for more effective patient education sessions. Whether it is therapy, device usage, or other areas, both pharmacists and technicians can enhance patient interactions with these principles.

Learning Objectives:
1. List current trends in third-party payor auditing practices and methods to respond effectively.
2. List common strategies to improve response success when responding to audits.
3. Differentiate a regulatory authority, the US Attorney's Office, and private-sector auditor.
4. Describe the requirements for most commercial and government payors regarding documentation.

Location: VERSAILLES 1

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-009-L04-P; 0113-0000-23-009-L04-T
12 - 1:30 pm
RODDY CHONG KEYNOTE & AWARDS CEREMONY
VENDOME A
1:30 - 3:30 pm
EXHIBIT HALL, POSTER SESSIONS, PRODUCT THEATER & LUNCH
RIVOLI A
3:30-5:00 pm
PHARMACY OWNERS RECEPTION SPONSORED BY AMBA
VERSAILLES 1
6:00 pm
REGISTRATION DESK CLOSES
Paris Las Vegas, Conference Center
8:30 - 11 pm
OH, LA, LA! A NIGHT IN PARIS
VENDOME A
7:00 am
REGISTRATION DESK OPENS
Paris Las Vegas, Conference Center
8:00 am
CAREER ROUNDTABLE
Melissa Kimura, PharmD & Vivian Truong, PharmD

Click for Description

Description: Students will get exposed to many different areas of pharmacy and learn the career paths of many traditional and non-traditional careers.



Location: VENDOME C

Click Here for Session Handouts

9:10-10:30 am
DR. MICHAEL HOGUE KEYNOTE & ANNUAL BUSINESS MEETING
VENDOME A
10:45 am
STRATEGIES FOR SUCCESS IN PHARMACY AS A STUDENT
Samantha Teshima, PharmD & Goldie Yavari, PharmD

Click for Description & Learning Objectives

Description: This program is targeted specifically towards pharmacy students - utilizing all the resources available to you, and maximizing your pharmacy school experience. This presentation will discuss the importance of leadership and how to find meaningful opportunities, leverage tips and tricks on how to study while working in the pharmacy, provide insight into navigating post-graduate opportunities, a timeline on how to apply to residency, and an overview on what to expect on the NAPLEX.

Learning Objectives:
1. Identify gaps in learning experiences and create a more balanced pharmacy school plan.
2. Recall important “high-yield” clinical topics in the workplace that are tested on pharmacy board exams.
3. Demonstrate critical thinking in working through a real-life example of reinforcing knowledge in the workplace.


Location: VENDOME C

Click Here for Session Handouts

12 - 1:30 pm
RODDY CHONG KEYNOTE & AWARDS CEREMONY
VENDOME A
1:30 - 3:30 pm
EXHIBIT HALL, POSTER SESSIONS, PRODUCT THEATER & LUNCH
RIVOLI A
3 - 5 pm
STUDENT PHARMACISTS QUIZ BOWL & STUDENT PHARMACISTS FILM FESTIVAL
VENDOME A
6:00 pm
REGISTRATION DESK CLOSES
Paris Las Vegas, Conference Center
8:30 - 11 pm
OH, LA, LA! A NIGHT IN PARIS
VENDOME A
8:30 am
QUALITY IMPROVEMENT IN THE LONG TERM CARE SETTING OPPORTUNITIES AND BARRIERS
George Do, PharmD

Click for Description & Learning Objectives

Description: This session will explore a Quality Improvement Project in the Long Term Care Setting aimed at addressing Readmission Rates. There will be a discussion overall about systematic ways to perform Quality Improvement and how to adapt a project according to changing circumstances.

Learning Objectives:
1. Define Quality Improvement. 2. Recognize the situation of readmission rates in the long term care setting.
3. Reproduce results in clinical studies to specific work settings.
4. Relate obstacles to quality improvement.
5. List the number of ways pharmacists can help.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-003-L01-P; 0113-0000-23-003-L01-T
8:30 am
THE TROUBLE WITH SPREADING PHARMACIST SERVICES
Michael Negrete, PharmD & Nancy Alvarez, PharmD

Click for Description & Learning Objectives

Description: In 1990, Hepler and Strand famously called for the pharmacy profession to "change the focus of practice from products...to ensuring the best drug therapy and patient safety". Unfortunately, 30-years later, the National Pharmacist Workforce Study shows that on average, across all practice settings, pharmacists still spend only a small fraction of their time performing "patient care services not associated with medication dispensing". This CE program will 1) introduce participants to John List's five "vital signs" that any service, product or idea must pass to have a chance for scale, and 2) facilitate a discussion about how well various "non-dispensing services" perform on each of those vital signs.

Learning Objectives:
1. List major efforts over the last 30 years to shift the focus of pharmacist responsibilities from products to services.
2. Identify the approximate percentage of time community pharmacists spend per week on patient care services not associated with medication dispensing.
3. List the 5 “vital signs” that indicate a product or service’s potential to achieve and sustain at scale.
4. Given a list of potential non-dispensing services, identify which one is most likely to achieve and sustain at scale.
5. Identify potential strategies for addressing the most challenging vital signs in relation to scaling non-dispensing services.

Location: CONCORDE B

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-012-L04-P; 0113-0000-23-012-L04-T
8:30 am
POLYPHARMACY AND DEPRESCRIBING IN OLDER ADULTS: THE ROLE OF THE PHARMACIST
Ala Babakhanians, PharmD, Tatyana Gurvich, PharmD, BCGP, & Shanon Vartanian, PharmD

Click for Description & Learning Objectives

Description: Polypharmacy has been a growing concern in the geriatric patient population, resulting in increased risk of adverse drug reactions, including falls and cognitive impairment, as well as increased risk of drug interactions and prescribing cascades. Given the lack of a consistent definition for polypharmacy, the session will accurately define the concept, and address risk factors and negative consequences in this patient population. It will also discuss evidence-based approaches to de-prescribing processes to improve patient care outcomes.

Learning Objectives:
1. Discuss medication use in older adults.
2. Describe polypharmacy in older adults.
3. Recognize risk factors and adverse events resulting from polypharmacy.
4. Select and implement appropriate assessment tools for identifying and addressing polypharmacy.
5. Identify approaches and challenges to de-prescribing practices.

Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-002-L01-P; 0113-0000-23-002-L01-T
9:45 am
PHARMACISTS AS GATEKEEPERS FOR SUICIDE PREVENTION
Nathan Painter, PharmD, CDCES, FADCES & Kelly Lee, Stan Collin, PharmD, MAS, APh, FCCP, BCPP

Click for Description & Learning Objectives

Description: This session will provide insight into the role pharmacists, as frontline responders, and gatekeepers, can play in suicide prevention. It will include an overview of suicide prevention, how to counsel on medications that are high in lethality or increase risk of suicidal thoughts, and a variety of resources. Attendees will walk away with an increased understanding on how to identify warning signs of suicide, how to have a conversation with a patient, and how to provide that patient with help.

Learning Objectives:
1. Describe the reasons why pharmacists are ideal gatekeepers for suicide prevention.
2. List the verbal and non-verbal warning signs for suicide.
3. Identify medication or disease risk factors for suicide.
4. Summarize the suicide screening questions to identify level of risk.
5. Refer patients who are at risk of suicide to community resources.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-013-L01-P; 0113-0000-23-013-L01-T
9:45 am
TREATMENT OF OCULAR ALLERGIES: MUCH MORE THAN ITCHY EYES! 
Martin J. Torres, PharmD & Emily Stephey, OD, FAAO

Click for Description & Learning Objectives

Description: Ocular allergies are so much more than just red, itchy eyes and without appropriate treatment in certain situations may be site threatening. Attendees will have the opportunity to learn about the pathophysiology of ocular allergies and the various prescription and OTC medications used in treatment.

Learning Objectives:
1. Describe the pathophysiology of the ocular inflammatory response responsible for the manifestations of allergic eye disease.
2. Compare the different medication classes and their mechanisms of action utilized in the treatment of ocular allergic reactions.
3. Differentiate between the indications, side effects, and contra- indications for each medication class used to treat ocular allergies.
4. Compare the OTC medications utilized to treat ocular allergies.
5. Identify the Pharmacist’s role in medication education.

Location: CONCORDE B

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-010-L01-P; 0113-0000-23-010-L01-T
9:45 am
HEP HEP HOORAY! WINNING THE FIGHT AGAINST HEPATITIS B
Cassandra Ferguson, PharmD, Edith Mirzaian, PharmD, BCACP, & Phuong Nhgi, Ngoc Le, PharmD

Click for Description & Learning Objectives

Description: Recent studies done by Advisory Committee of Immunization Practices (ACIP) have demonstrated suboptimal immunity and increasing incidence rates of Hepatitis B in specific patient populations. This program will highlight changes in Hepatitis B infection and immunity rates and focus on prevention, treatment and immunization guideline updates being used to combat an increasing concern regarding Hepatitis B incidence rates.

Learning Objectives:
1. Describe the pathophysiology of Hepatitis B infection.
2. Interpret the results of a Hepatitis B serology test.
3. Discuss current treatment options for Hepatitis B infection.
4. Describe the current recommendations for Hepatitis B vaccines.
5. Explain the role of the pharmacist in improving vaccination rates for Hepatitis B.

Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-013-L01-P; 0113-0000-23-013-L01-T
8:30 am
QUALITY IMPROVEMENT IN THE LONG TERM CARE SETTING OPPORTUNITIES AND BARRIERS
George Do, PharmD

Click for Description & Learning Objectives

Description: This session will explore a Quality Improvement Project in the Long Term Care Setting aimed at addressing Readmission Rates. There will be a discussion overall about systematic ways to perform Quality Improvement and how to adapt a project according to changing circumstances.

Learning Objectives:
1. Define Quality Improvement. 2. Recognize the situation of readmission rates in the long term care setting.
3. Reproduce results in clinical studies to specific work settings.
4. Relate obstacles to quality improvement.
5. List the number of ways pharmacists can help.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-003-L01-P; 0113-0000-23-003-L01-T
8:30 am
THE TROUBLE WITH SPREADING PHARMACIST SERVICES
Michael Negrete, PharmD & Nancy Alvarez, PharmD

Click for Description & Learning Objectives

Description: In 1990, Hepler and Strand famously called for the pharmacy profession to "change the focus of practice from products...to ensuring the best drug therapy and patient safety". Unfortunately, 30-years later, the National Pharmacist Workforce Study shows that on average, across all practice settings, pharmacists still spend only a small fraction of their time performing "patient care services not associated with medication dispensing". This CE program will 1) introduce participants to John List's five "vital signs" that any service, product or idea must pass to have a chance for scale, and 2) facilitate a discussion about how well various "non-dispensing services" perform on each of those vital signs.

Learning Objectives:
1. List major efforts over the last 30 years to shift the focus of pharmacist responsibilities from products to services.
2. Identify the approximate percentage of time community pharmacists spend per week on patient care services not associated with medication dispensing.
3. List the 5 “vital signs” that indicate a product or service’s potential to achieve and sustain at scale.
4. Given a list of potential non-dispensing services, identify which one is most likely to achieve and sustain at scale.
5. Identify potential strategies for addressing the most challenging vital signs in relation to scaling non-dispensing services.

Location: CONCORDE B

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-012-L04-P; 0113-0000-23-012-L04-T
8:30 am
POLYPHARMACY AND DEPRESCRIBING IN OLDER ADULTS: THE ROLE OF THE PHARMACIST
Ala Babakhanians, PharmD, Tatyana Gurvich, PharmD, BCGP, & Shanon Vartanian, PharmD

Click for Description & Learning Objectives

Description: Polypharmacy has been a growing concern in the geriatric patient population, resulting in increased risk of adverse drug reactions, including falls and cognitive impairment, as well as increased risk of drug interactions and prescribing cascades. Given the lack of a consistent definition for polypharmacy, the session will accurately define the concept, and address risk factors and negative consequences in this patient population. It will also discuss evidence-based approaches to de-prescribing processes to improve patient care outcomes.

Learning Objectives:
1. Discuss medication use in older adults.
2. Describe polypharmacy in older adults.
3. Recognize risk factors and adverse events resulting from polypharmacy.
4. Select and implement appropriate assessment tools for identifying and addressing polypharmacy.
5. Identify approaches and challenges to de-prescribing practices.

Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-002-L01-P; 0113-0000-23-002-L01-T
9:45 am
PHARMACISTS AS GATEKEEPERS FOR SUICIDE PREVENTION
Nathan Painter, PharmD, CDCES, FADCES & Kelly Lee, Stan Collin, PharmD, MAS, APh, FCCP, BCPP

Click for Description & Learning Objectives

Description: This session will provide insight into the role pharmacists, as frontline responders, and gatekeepers, can play in suicide prevention. It will include an overview of suicide prevention, how to counsel on medications that are high in lethality or increase risk of suicidal thoughts, and a variety of resources. Attendees will walk away with an increased understanding on how to identify warning signs of suicide, how to have a conversation with a patient, and how to provide that patient with help.

Learning Objectives:
1. Describe the reasons why pharmacists are ideal gatekeepers for suicide prevention.
2. List the verbal and non-verbal warning signs for suicide.
3. Identify medication or disease risk factors for suicide.
4. Summarize the suicide screening questions to identify level of risk.
5. Refer patients who are at risk of suicide to community resources.

Location: CONCORDE A

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-013-L01-P; 0113-0000-23-013-L01-T
9:45 am
TREATMENT OF OCULAR ALLERGIES: MUCH MORE THAN ITCHY EYES! 
Martin J. Torres, PharmD & Emily Stephey, OD, FAAO

Click for Description & Learning Objectives

Description: Ocular allergies are so much more than just red, itchy eyes and without appropriate treatment in certain situations may be site threatening. Attendees will have the opportunity to learn about the pathophysiology of ocular allergies and the various prescription and OTC medications used in treatment.

Learning Objectives:
1. Describe the pathophysiology of the ocular inflammatory response responsible for the manifestations of allergic eye disease.
2. Compare the different medication classes and their mechanisms of action utilized in the treatment of ocular allergic reactions.
3. Differentiate between the indications, side effects, and contra- indications for each medication class used to treat ocular allergies.
4. Compare the OTC medications utilized to treat ocular allergies.
5. Identify the Pharmacist’s role in medication education.

Location: CONCORDE B

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-010-L01-P; 0113-0000-23-010-L01-T
9:45 am
HEP HEP HOORAY! WINNING THE FIGHT AGAINST HEPATITIS B
Cassandra Ferguson, PharmD, Edith Mirzaian, PharmD, BCACP, & Phuong Nhgi, Ngoc Le, PharmD

Click for Description & Learning Objectives

Description: Recent studies done by Advisory Committee of Immunization Practices (ACIP) have demonstrated suboptimal immunity and increasing incidence rates of Hepatitis B in specific patient populations. This program will highlight changes in Hepatitis B infection and immunity rates and focus on prevention, treatment and immunization guideline updates being used to combat an increasing concern regarding Hepatitis B incidence rates.

Learning Objectives:
1. Describe the pathophysiology of Hepatitis B infection.
2. Interpret the results of a Hepatitis B serology test.
3. Discuss current treatment options for Hepatitis B infection.
4. Describe the current recommendations for Hepatitis B vaccines.
5. Explain the role of the pharmacist in improving vaccination rates for Hepatitis B.

Location: CONCORDE C

Click Here for Session Handouts

1.0 CE Hour 0113-0000-23-013-L01-P; 0113-0000-23-013-L01-T
8:30 am
YOU'RE HIRED: HOW TO MAKE A LASTING IMPRESSION ON YOUR PRECEPTORS
Jennifer Courtney, PharmD & Patrick Tabon, PharmD, APh, BCPS, BCGP, BCACP

Click for Description & Learning Objectives

Description: Tips and tricks to getting the most out of your clinical pharmacy rotation and making a positive impression on your preceptor. The session will emphasize skills and traits that future employers look for in potential job and residency candidates.

Learning Objectives:
1. Discuss best practices for students going on clinical rotations.
2. Construct an introductory email to a preceptor for each of your rotations.
3. Describe common pitfalls students fall into during rotations.
4. Develop a plan to overcome challenges and pitfalls during your rotations.

Location: RIVOLI A

Click Here for Session Handouts

9:45 am
TICK TOCK!  TIME TO EXERT YOUR CONTROL OF 1,440 MINUTES
Brian I. Kawahara, PharmD & Nancy Alvarez, PharmD

Click for Description & Learning Objectives

Description: We all are given the same amount of time each day – 1,440 minutes. How you spend 1,440 minutes can be the difference between having your life in or out of control. This session will help you identify tools and ideas to develop a time investment plan that optimizes your return on time invested.

Learning Objectives:
1. Describe how time investment contributes to and detracts from well-being.
2. Identify 2 strategies to optimize the use of 1,440 minutes per day.
3. Analyze a situation where you need to say no to participate in an activity and create 2 statements to graciously decline the invitation.

Location: RIVOLI A

Click Here for Session Handouts

Share

About Our Blog

Iterative approaches to corporate strategy foster collaborative thinking to further the overall value proposition.
April 12-14, 2019
JW Marriott L.A. Live
900 Olympic Blvd, Los Angeles, CA 90015

Top Rated